Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
1(0/1/0)
|
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
12q24.11 |
2(0/2/0)
|
NOS1 |
nitric oxide synthase 1 (neuronal) |
12q24.22 |
8(2/5/1)
|
CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
9q34 |
1(1/0/0)
|
ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
ADRA1B |
adrenoceptor alpha 1B |
5q33.3 |
1(1/0/0)
|
P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16q24.1 |
1(0/1/0)
|
ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
18p11.22-p11.21 |
2(0/2/0)
|
PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
7q36.1 |
2(1/1/0)
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
Xq23 |
7(4/3/0)
|
CCKBR |
cholecystokinin B receptor |
11p15.4 |
1(1/0/0)
|
PLCG1 |
phospholipase C, gamma 1 |
20q12-q13.1 |
1(0/1/0)
|
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
1(1/0/0)
|
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
ADRB2 |
adrenoceptor beta 2, surface |
5q31-q32 |
1(1/0/0)
|
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25.3 |
1(1/0/0)
|
ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
BDKRB1 |
bradykinin receptor B1 |
14q32.1-q32.2 |
1(1/0/0)
|
CHRM5 |
cholinergic receptor, muscarinic 5 |
15q26 |
1(0/1/0)
|
PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
5q32 |
2(1/1/0)
|
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
DRD5 |
dopamine receptor D5 |
4p16.1 |
2(0/2/0)
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
DRD1 |
dopamine receptor D1 |
5q34-q35 |
11(6/5/0)
|
CHRM2 |
cholinergic receptor, muscarinic 2 |
7q35-q36 |
1(0/1/0)
|
OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
5q31-q33 |
2(1/1/0)
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme |
8p21.3 |
1(0/1/0)
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
3(2/1/0)
|
GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
19q13.33 |
1(1/0/0)
|
TACR1 |
tachykinin receptor 1 |
2p13.1-p12 |
3(3/0/0)
|
CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
1(0/1/0)
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
1q43 |
1(0/1/0)
|
RYR2 |
ryanodine receptor 2 (cardiac) |
1q43 |
1(1/0/0)
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
20(17/3/0)
|
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
7q36 |
2(1/1/0)
|
GNAS |
GNAS complex locus |
20q13.2-q13.3 |
1(0/1/0)
|
TRHR |
thyrotropin-releasing hormone receptor |
8q23.1 |
1(0/1/0)
|
AVPR1B |
arginine vasopressin receptor 1B |
1q32 |
4(3/1/0)
|
BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
1(1/0/0)
|
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
10q21-q24 |
2(0/2/0)
|
ADORA2B |
adenosine A2b receptor |
17p12 |
1(1/0/0)
|